Thermo Fisher Scientific’s Accelerator™ Drug Development is a suite of integrated services combining CDMO and CRO capabilities to streamline the drug development journey, from early-stage research to commercialization. As a single, connected partner for clinical research, manufacturing, and clinical supply chain management, we can drive greater efficiency and mitigate risks, enabling companies to get their new medicines and therapies to market faster, across all major therapeutic areas and drug modalities.